Dupilumab Subcutaneous and NovoSeven RT with MixPro injection
Determining the interaction of Dupilumab Subcutaneous and NovoSeven RT with MixPro injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection), NovoSeven RT
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Novothyrox
- Dupilumab Subcutaneous-Noxafil
- Dupilumab Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- Dupilumab Subcutaneous-Noxafil (Posaconazole Injection)
- Dupilumab Subcutaneous-Noxafil (Posaconazole Oral Suspension)
- Dupilumab Subcutaneous-Noxafil Intravenous
- NovoSeven RT with MixPro injection-Dupixent
- NovoSeven RT with MixPro injection-Duplex T Topical
- NovoSeven RT with MixPro injection-Durachol
- NovoSeven RT with MixPro injection-Duraclon
- NovoSeven RT with MixPro injection-Duraclon injection
- NovoSeven RT with MixPro injection-Duraflu